Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2024)Top healthcare stocks in 2024 ranked by overall Zen Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.
Sectors & IndustriesHealthcare
Sector: Healthcare
| Ticker | Company | Country | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|
| DHAI | DIH HOLDING US INC | United States | $64.87M | 40,544,935 | 1.06% | 46.79% | ||
| DRMA | DERMATA THERAPEUTICS INC | United States | $1.67M | 444,056 | 1.02% | 98.98% | ||
| RNXT | RENOVORX INC | United States | $33.53M | 23,951,825 | 1.38% | 14.26% | Net Buying | |
| ELTX | ELICIO THERAPEUTICS INC | United States | $101.27M | 10,270,285 | 3.96% | 92.23% | Net Buying | |
| EHAB | ENHABIT INC | United States | $448.89M | 50,155,417 | 97.76% | 2.24% | Net Buying | Net Buying |
| ELAN | ELANCO ANIMAL HEALTH INC | United States | $8.40B | 494,181,620 | 90.47% | 9.53% | Net Selling | Net Selling |
| GRTX | GALERA THERAPEUTICS INC | United States | $10.12M | 54,392,170 | 17.98% | 73.20% | Net Selling | Net Selling |
| BTSG | BRIGHTSPRING HEALTH SERVICES INC | United States | $1.96B | 171,320,174 | 48.31% | 51.69% | Net Buying | Net Buying |
| SOLV | SOLVENTUM CORP | United States | $10.71B | 172,709,505 | 2.87% | 19.90% | ||
| ISPC | ISPECIMEN INC | United States | $2.47M | 9,978,958 | 3.00% | 64.70% | Net Buying | |
| MTEM | MOLECULAR TEMPLATES INC | United States | $9.41M | 6,583,880 | 1.87% | 98.13% | Net Buying | Net Buying |
| BIOL | BIOLASE INC | United States | $5.38M | 33,394,979 | 1.42% | 55.47% | ||
| VERO | VENUS CONCEPT INC | Canada | $4.00M | 6,355,230 | 1.60% | 98.40% | ||
| MNDR | MOBILE-HEALTH NETWORK SOLUTIONS | Cayman Islands | $65.62M | 34,000,000 | 0.00% | 0.00% | ||
| SHPH | SHUTTLE PHARMACEUTICALS HOLDINGS INC | United States | $6.99M | 16,794,893 | 0.33% | 59.49% | Net Selling | |
| OPGN | OPGEN INC | United States | $3.87M | 1,001,352 | 2.19% | 97.81% | ||
| CTNM | CONTINEUM THERAPEUTICS INC | United States | $404.11M | 25,723,276 | 0.00% | 10.47% | ||
| MYMD | MYMD PHARMACEUTICALS INC | United States | $5.49M | 2,307,632 | 11.18% | 88.82% | Net Buying | |
| AXDX | ACCELERATE DIAGNOSTICS INC | United States | $19.34M | 22,050,515 | 6.16% | 93.84% | Net Buying | Net Selling |
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Israel | $19.04B | 1,132,640,597 | 50.23% | 0.96% | Net Selling | Net Selling |
| KA | KINETA INC | United States | $5.89M | 12,254,455 | 4.35% | 95.65% | Net Buying | Net Buying |
| CADL | CANDEL THERAPEUTICS INC | United States | $356.34M | 29,744,731 | 12.71% | 37.04% | Net Selling | |
| RENB | RENOVARO INC | United States | $143.08M | 147,504,944 | 4.92% | 79.84% | Net Buying | |
| RANI | RANI THERAPEUTICS HOLDINGS INC | United States | $264.71M | 50,420,315 | 6.18% | 51.39% | Net Buying | |
| AONC | AMERICAN ONCOLOGY NETWORK INC | United States | $96.71M | 36,772,340 | 0.27% | 19.03% | Net Selling | Net Buying |
| CPHI | CHINA PHARMA HOLDINGS INC | China | $5.67M | 15,870,070 | 0.22% | 99.78% | Net Buying | |
| ANVS | ANNOVIS BIO INC | United States | $97.75M | 11,171,480 | 10.85% | 26.53% | Net Buying | |
| ENGN | ENGENE HOLDINGS INC | Canada | $552.18M | 43,581,331 | 72.24% | 27.76% | Net Buying | Net Buying |
| EFTR | EFFECTOR THERAPEUTICS INC | United States | $8.80M | 4,704,409 | 1.86% | 98.14% | Net Selling | Net Buying |
| ZVSA | ZYVERSA THERAPEUTICS INC | United States | $3.51M | 834,896 | 2.68% | 97.32% | ||
| NUWE | NUWELLIS INC | United States | $4.64M | 18,051,055 | 1.34% | 68.58% | ||
| PMN | PROMIS NEUROSCIENCES INC | Canada | $34.98M | 18,961,116 | 17.84% | 24.49% | ||
| VRPX | VIRPAX PHARMACEUTICALS INC | United States | $905.36k | 1,171,233 | 0.02% | 99.98% | ||
| LIFW | MSP RECOVERY INC | United States | $98.88M | 140,250,854 | 1.22% | 13.40% | Net Buying | Net Selling |
| TTOO | T2 BIOSYSTEMS INC | United States | $53.29M | 8,792,950 | 0.32% | 99.68% | Net Selling | |
| BPTH | BIO-PATH HOLDINGS INC | United States | $3.59M | 1,656,235 | 0.11% | 99.89% | ||
| COCH | ENVOY MEDICAL INC | United States | $63.50M | 19,599,982 | 5.92% | 73.05% | Net Buying | |
| NRSN | NEUROSENSE THERAPEUTICS LTD | Israel | $19.38M | 15,379,042 | 1.09% | 0.00% | ||
| QLGN | QUALIGEN THERAPEUTICS INC | United States | $1.86M | 6,307,371 | 1.33% | 98.67% | ||
| ALZN | ALZAMEND NEURO INC | United States | $4.35M | 6,866,846 | 0.93% | 99.07% | Net Buying | Net Buying |
| CNSP | CNS PHARMACEUTICALS INC | United States | $2.56M | 11,851,932 | 7.41% | 4.75% | Net Buying | |
| CNTG | CENTOGENE NV | Germany | $10.51M | 27,595,835 | 7.76% | 0.00% | ||
| HCWB | HCW BIOLOGICS INC | United States | $41.98M | 37,823,394 | 2.91% | 47.89% | Net Buying | |
| MOVE | MOVANO INC | United States | $42.65M | 98,265,068 | 9.24% | 10.19% | Net Buying | |
| WINT | WINDTREE THERAPEUTICS INC | United States | $2.59M | 591,909 | 0.71% | 99.29% | Net Buying | |
| AMRX | AMNEAL PHARMACEUTICALS INC | $2.08B | 308,651,373 | 25.00% | 75.00% | Net Selling | Net Selling | |
| NRXP | NRX PHARMACEUTICALS INC | United States | $43.44M | 10,700,609 | 5.85% | 94.15% | Net Buying | |
| IVA | INVENTIVA SA | France | $193.14M | 52,115,807 | 9.29% | 0.00% | ||
| AGEN | AGENUS INC | United States | $224.69M | 20,999,261 | 60.95% | 39.05% | Net Buying | Net Buying |
| ARMP | ARMATA PHARMACEUTICALS INC | United States | $89.66M | 36,154,617 | 1.70% | 98.30% | ||
| AKTX | AKARI THERAPEUTICS PLC | United States | $24.09M | 15,847,391,523 | 0.00% | 59.09% | ||
| CUTR | CUTERA INC | United States | $45.36M | 20,072,096 | 66.01% | 33.99% | Net Selling | Net Selling |
| CERO | CERO THERAPEUTICS HOLDINGS INC | United States | $15.97M | 15,062,258 | 11.06% | 21.61% | ||
| XFOR | X4 PHARMACEUTICALS INC | United States | $151.14M | 167,937,781 | 61.33% | 1.30% | Net Selling | Net Selling |
| ALLR | ALLARITY THERAPEUTICS INC | United States | $11.04M | 17,606,739 | 0.22% | 7.15% | ||
| OKYO | OKYO PHARMA LTD | United Kingdom | $38.07M | 25,553,274 | 0.17% | 99.83% | Net Buying | |
| BCTX | BRIACELL THERAPEUTICS CORP | Canada | $23.81M | 15,981,726 | 13.73% | 28.25% | Net Buying | Net Buying |
| VINC | VINCERX PHARMA INC | United States | $20.14M | 29,534,238 | 28.70% | 38.94% | Net Buying | |
| LSDI | LUCY SCIENTIFIC DISCOVERY INC | Canada | $2.28M | 1,764,630 | 6.20% | 93.80% | ||
| AMIX | AUTONOMIX MEDICAL INC | United States | $43.41M | 18,793,974 | 0.18% | 35.88% | ||
| CDT | CONDUIT PHARMACEUTICALS INC | United States | $214.84M | 73,829,536 | 2.18% | 73.51% | ||
| BOLD | BOUNDLESS BIO INC | United States | $236.34M | 22,254,537 | 65.14% | 23.96% | Net Buying | Net Buying |
| FBLG | FIBROBIOLOGICS INC | United States | $359.91M | 32,719,125 | 1.47% | 0.39% | ||
| ONMD | ONEMEDNET CORP | United Kingdom | $11.21M | 23,850,010 | 4.45% | 27.05% | Net Selling | |
| ONCO | ONCONETIX INC | United States | $3.55M | 22,327,701 | 10.58% | 21.37% | ||
| PACS | PACS GROUP INC | United States | $4.22B | 147,773,386 | 0.00% | 89.87% | Net Selling | Net Selling |
| ICU | SEASTAR MEDICAL HOLDING CORP | United States | $30.92M | 75,419,458 | 5.06% | 19.86% | Net Buying | |
| NRXS | NEURAXIS INC | United States | $19.74M | 6,647,960 | 1.12% | 39.67% | Net Buying | |
| GALT | GALECTIN THERAPEUTICS INC | United States | $196.39M | 62,148,134 | 8.77% | 91.23% | Net Buying | Net Selling |
| OTLK | OUTLOOK THERAPEUTICS INC | United States | $186.07M | 23,405,637 | 3.76% | 96.24% | Net Buying | Net Buying |
| MAIA | MAIA BIOTECHNOLOGY INC | United States | $74.46M | 21,837,149 | 2.88% | 20.26% | Net Buying | Net Buying |
| MDAI | SPECTRAL AI INC | United States | $32.17M | 17,482,333 | 15.55% | 77.10% | Net Buying | Net Buying |
| ALUR | ALLURION TECHNOLOGIES INC | United States | $81.03M | 47,947,952 | 15.77% | 16.50% | Net Buying | |
| ERNA | ETERNA THERAPEUTICS INC | United States | $11.25M | 5,410,331 | 0.43% | 99.57% | Net Selling | |
| NLSP | NLS PHARMACEUTICS LTD | Switzerland | $6.31M | 35,671,780 | 22.87% | 0.00% | ||
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS INC | United States | $42.99M | 27,918,560 | 19.44% | 38.25% | ||
| BCLI | BRAINSTORM CELL THERAPEUTICS INC | United States | $39.74M | 70,080,523 | 5.77% | 53.09% | Net Buying | Net Buying |
| AEON | AEON BIOPHARMA INC | United States | $66.51M | 39,122,238 | 24.21% | 59.31% | Net Selling | |
| BGXX | BRIGHT GREEN CORP | United States | $42.60M | 190,166,318 | 5.61% | 67.06% | Net Buying | |
| NKGN | NKGEN BIOTECH INC | United States | $42.56M | 24,887,799 | 12.13% | 80.06% | Net Buying | |
| CLDI | CALIDI BIOTHERAPEUTICS INC | United States | $12.63M | 50,924,284 | 5.27% | 34.31% | Net Selling | Net Buying |
| PBM | PSYENCE BIOMEDICAL LTD | Canada | $11.72M | 13,390,659 | 5.34% | 66.53% | Net Selling | |
| OCEA | OCEAN BIOMEDICAL INC | United States | $55.32M | 34,149,046 | 13.26% | 75.32% | ||
| TVGN | TEVOGEN BIO HOLDINGS INC | United States | $128.40M | 164,614,418 | 4.11% | 95.89% | Net Selling | |
| NIVF | NEWGENIVF GROUP LTD | Thailand | $10.93M | 8,284,000 | 15.56% | 20.82% | ||
| NUVO | LAMF GLOBAL VENTURES CORP I | United States | $23.41M | 13,223,440 | 8.43% | 72.14% | ||
| INKT | MINK THERAPEUTICS INC | United States | $35.07M | 34,727,639 | 2.70% | 71.96% | Net Buying | Net Buying |
Healthcare Industries
| Industry | Stocks | 1d % | 1w % | 1m % | 1y % | Zen Score | P/E ratio | P/B Ratio | ROE | ROA | ROCE | Upside/Downside | Consensus |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 678 | +0.74% | +2.09% | +6.36% | -20.75% | 8.16x | 6.06x | +18.37% | +3.70% | -27.15% | +77.15% | Strong Buy | ||
| 64 | -0.34% | +2.22% | +12.40% | +8.46% | 39.05x | 4.47x | -13.16% | +6.46% | +11.46% | +5.34% | Buy | ||
| 18 | +0.48% | +1.89% | +7.64% | +18.88% | 32.93x | 6.42x | +33.66% | +8.08% | +14.20% | +10.49% | Buy | ||
| 87 | +0.27% | +0.58% | +6.24% | -3.67% | -1.08x | 2.21x | +12.46% | +3.39% | +6.12% | +31.76% | Strong Buy | ||
| 12 | -1.10% | +0.04% | +1.12% | +4.69% | 25.19x | 3.03x | +15.18% | +4.74% | +11.78% | +13.37% | Buy | ||
| 61 | -0.19% | +1.63% | -1.19% | -22.50% | 10.68x | 3.32x | +6.76% | +2.25% | +5.35% | +27.15% | Buy | ||
| 51 | +0.19% | +0.62% | +4.65% | +11.39% | 37.64x | 4.62x | -92.27% | +6.58% | +13.67% | +14.97% | Buy | ||
| 150 | -0.33% | +1.75% | +3.10% | -14.72% | 30.55x | 3.98x | +7.33% | +5.24% | +8.23% | +20.25% | Buy | ||
| 10 | -0.52% | +0.61% | +0.95% | +26.67% | 26.75x | 106.68x | -12.18% | +3.44% | +19.61% | +11.48% | Buy | ||
| 56 | -0.23% | +1.99% | +6.12% | -6.85% | 59.90x | 3.63x | +11.21% | +7.72% | +10.03% | +18.87% | Buy |
Healthcare Stocks FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.